Literature DB >> 25483088

miR-214-mediated downregulation of RNF8 induces chromosomal instability in ovarian cancer cells.

Zheng Wang1, Hao Yin, Yuanwei Zhang, Yukun Feng, Zhaofeng Yan, Xiaohua Jiang, Ihtisham Bukhari, Furhan Iqbal, Howard J Cooke, Qinghua Shi.   

Abstract

Defective DNA damage response (DDR) is frequently associated with carcinogenesis. Abrogation of DDR leads to chromosomal instability, a most common characteristic of tumors. However, the molecular mechanisms underlying regulation of DDR are still elusive. The ubiquitin ligase RNF8 mediates the ubiquitination of γH2AX and recruits 53BP1 and BRCA1 to DNA damage sites which promotes DDR and inhibits chromosomal instability. Though RNF8 is a key player involved in DDR, regulation of its expression is still poorly understood. Here, we show that miR-214 could abrogate DDR by repressing RNF8 expression through direct binding to 3'-untranslated region (3' UTR) of RNF8 mRNA in human ovarian cancer cells. Antagonizing miR-214 by expressing its inhibitors in A2780 cells significantly increased RNF8 expression and thus promoted DNA damage repair. Consistent with the role of miR-214 in regulating RNF8 expression, the impaired DNA repair induced by miR-214 overexpression can be rescued by overexpressing RNF8 mRNA lacking the 3' UTR. Together, our results indicate that down-regulation of RNF8 mediated by miR-214 impedes DNA damage response to induce chromosomal instability in ovarian cancers, which may facilitate the understanding of mechanisms underlying chromosomal instability.

Entities:  

Keywords:  3′ UTR, 3′untranslated region; CIN, Chromosomal instability; DDR, DNA damage response; DNA damage response; RNF8; chromosomal instability; miRNA; miRNAs, microRNAs; ovarian cancer

Mesh:

Substances:

Year:  2014        PMID: 25483088      PMCID: PMC4615040          DOI: 10.4161/15384101.2014.958413

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  63 in total

1.  A functional polymorphism at microRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population.

Authors:  Lei Yang; Yinyan Li; Mei Cheng; Dongsheng Huang; Jian Zheng; Bin Liu; Xiaoxuan Ling; Qingchu Li; Xin Zhang; Weidong Ji; Yifeng Zhou; Jiachun Lu
Journal:  Carcinogenesis       Date:  2011-11-22       Impact factor: 4.944

2.  Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.

Authors:  Keitaro Yamane; Masatoshi Jinnin; Tomomi Etoh; Yuki Kobayashi; Naoki Shimozono; Satoshi Fukushima; Shinichi Masuguchi; Keishi Maruo; Yuji Inoue; Tsuyoshi Ishihara; Jun Aoi; Yuichi Oike; Hironobu Ihn
Journal:  J Mol Med (Berl)       Date:  2012-07-25       Impact factor: 4.599

Review 3.  In brief: BRCA1 and BRCA2.

Authors:  William D Foulkes; Andrew Y Shuen
Journal:  J Pathol       Date:  2013-08       Impact factor: 7.996

4.  BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.

Authors:  Kathryn Alsop; Sian Fereday; Cliff Meldrum; Anna deFazio; Catherine Emmanuel; Joshy George; Alexander Dobrovic; Michael J Birrer; Penelope M Webb; Colin Stewart; Michael Friedlander; Stephen Fox; David Bowtell; Gillian Mitchell
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

5.  MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression.

Authors:  Yemin Wang; Jen-Wei Huang; Ming Li; Webster K Cavenee; Patrick S Mitchell; Xiaofeng Zhou; Muneesh Tewari; Frank B Furnari; Toshiyasu Taniguchi
Journal:  Mol Cancer Res       Date:  2011-06-21       Impact factor: 5.852

Review 6.  Defining 'chromosomal instability'.

Authors:  Jochen B Geigl; Anna C Obenauf; Thomas Schwarzbraun; Michael R Speicher
Journal:  Trends Genet       Date:  2008-01-14       Impact factor: 11.639

7.  Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.

Authors:  Zhigang Wang; Haikang Cai; Lijun Lin; Mingjie Tang; Haiqing Cai
Journal:  Pediatr Blood Cancer       Date:  2013-09-09       Impact factor: 3.167

8.  MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN.

Authors:  Ting-Song Yang; Xiao-Hu Yang; Xu-Dong Wang; Yi-Ling Wang; Bo Zhou; Zhen-Shun Song
Journal:  Cancer Cell Int       Date:  2013-07-08       Impact factor: 5.722

9.  MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.

Authors:  Sheng-Dong Huang; Yang Yuan; Chong-Wen Zhuang; Bai-Ling Li; De-Jun Gong; Shu-Gang Wang; Zhi-Yong Zeng; He-Zhong Cheng
Journal:  Mol Cancer       Date:  2012-08-06       Impact factor: 27.401

10.  Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.

Authors:  Joshua Z Press; Alessandro De Luca; Niki Boyd; Sean Young; Armelle Troussard; Yolanda Ridge; Pardeep Kaurah; Steve E Kalloger; Katherine A Blood; Margaret Smith; Paul T Spellman; Yuker Wang; Dianne M Miller; Doug Horsman; Malek Faham; C Blake Gilks; Joe Gray; David G Huntsman
Journal:  BMC Cancer       Date:  2008-01-22       Impact factor: 4.430

View more
  15 in total

Review 1.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

2.  Histone acetyltransferase KAT8 is essential for mouse oocyte development by regulating reactive oxygen species levels.

Authors:  Shi Yin; Xiaohua Jiang; Hanwei Jiang; Qian Gao; Fang Wang; Suixing Fan; Teka Khan; Nazish Jabeen; Manan Khan; Asim Ali; Peng Xu; Tej K Pandita; Heng-Yu Fan; Yuanwei Zhang; Qinghua Shi
Journal:  Development       Date:  2017-05-15       Impact factor: 6.868

3.  miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.

Authors:  Qijue Lu; Li Xu; Chunguang Li; Yang Yuan; Shengdong Huang; Hezhong Chen
Journal:  Tumour Biol       Date:  2016-09-12

Review 4.  miRNA dysregulation is an emerging modulator of genomic instability.

Authors:  Ana P Ferragut Cardoso; Mayukh Banerjee; Alexandra N Nail; Angeliki Lykoudi; J Christopher States
Journal:  Semin Cancer Biol       Date:  2021-05-09       Impact factor: 15.707

Review 5.  Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer.

Authors:  Rosanna H E Krakowsky; Trygve O Tollefsbol
Journal:  Front Nutr       Date:  2015-05-27

6.  Increasing sensitivity to DNA damage is a potential driver for human ovarian cancer.

Authors:  Yimei Jin; Xin Xu; Xuemeng Wang; Henry Kuang; Michael Osterman; Shi Feng; Deqiang Han; Yu Wu; Mo Li; Hongyan Guo
Journal:  Oncotarget       Date:  2016-08-02

Review 7.  MicroRNA in Glioblastoma: An Overview.

Authors:  Barbara Banelli; Alessandra Forlani; Giorgio Allemanni; Anna Morabito; Maria Pia Pistillo; Massimo Romani
Journal:  Int J Genomics       Date:  2017-11-06       Impact factor: 2.326

8.  Role of miR-214 in modulating proliferation and invasion of human colon cancer SW620 cells.

Authors:  Haiying Nie; Dandan Nie; Lan Men
Journal:  Oncol Lett       Date:  2018-09-28       Impact factor: 2.967

Review 9.  Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer.

Authors:  Arkadiusz Gajek; Patrycja Gralewska; Agnieszka Marczak; Aneta Rogalska
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

10.  The expression of miRNAs is associated with tumour genome instability and predicts the outcome of ovarian cancer patients treated with platinum agents.

Authors:  Tianzhen Wang; Guangyu Wang; Xiaoxiao Zhang; Di Wu; Lei Yang; Guangyou Wang; Dapeng Hao
Journal:  Sci Rep       Date:  2017-11-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.